IP Library Granted Patent US 7,485,319
Granted Patent B2
US 7,485,319 · App. 10/896,045 · Granted Feb 3, 2009

Doxycycline metal complex in a solid dosage form

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,485,319
App. No.
10/896,045
Granted
Feb 3, 2009
Kind
B2
Abstract

The present invention is a solid dosage form of a doxycycline metal complex. The present invention also includes a process for making a doxycycline metal complex in a solid dosage form. The process comprises the steps of (i) providing an aqueous solution of doxycycline or a physiologically acceptable salt thereof; (ii) admixing a metal salt with the aqueous solution; (iii) admixing a base to increase the pH of the aqueous solution, thereby forming a suspension of doxycycline metal; and (iv) drying the suspension, thereby forming a dry granulation of doxycycline metal complex.

Claims (20)

1. A process for making a solid dosage form comprising a doxycycline calcium complex, wherein the complex consists of doxycycline and calcium, the process comprising the steps of:

(i) providing an aqueous solution of doxycycline or a physiologically acceptable salt thereof;

(ii) admixing a calcium salt with said aqueous solution;

(iii) admixing a base to increase the pH of said aqueous solution, thereby forming a suspension of doxycycline calcium complex; and

(iv) drying said suspension, thereby forming a dry granulation of doxycycline calcium complex.

2. The process of claim 1 , wherein said aqueous solution of doxycycline or a physiologically acceptable salt thereof is made by dissolving doxycycline or a physiologically acceptable salt thereof in an aqueous solution resulting in a solution with a pH range of about 1 to about 8.

3. The process of claim 1 , wherein said calcium salt is calcium chloride.

4. The process of claim 1 , wherein said base is sodium hydroxide.

5. The process of claim 1 , wherein said granulation has a moisture level of less than about 10 wt. %.

6. The process of claim 1 , wherein said drying step is performed by a process selected from the group consisting of: spray drying, fluid-bed drying, tray drying, decanting, evaporating, freeze drying, and combinations thereof.

7. The process of claim 1 , further comprising the step of admixing one or more pharmaceutically acceptable-excipients, prior to said drying step.

8. The process of claim 1 , further comprising the step of admixing one or more pharmaceutically acceptable-excipients, after forming said granulation.

9. The process of claim 1 , further comprising the step of compressing said granulation, thereby forming tablets.

10. The process of claim 1 , wherein said doxycycline or a physiologically acceptable salt thereof is selected from the group consisting of: doxycycline hyclate, doxycycline monohydrate, doxycycline carrageenate, doxycycline phosphate, and mixtures thereof.

11. A process for making a solid dosage form comprising a doxycycline calcium complex, wherein the complex consists of doxycycline and calcium, the process comprising the steps of:

(i) providing an aqueous solution of doxycycline or a physiologically acceptable salt thereof;

(ii) admixing a calcium salt with said aqueous solution;

(iii) admixing a base to increase the pH of said solution, thereby forming a suspension of doxycycline calcium complex;

(iv) admixing one or more pharmaceutically acceptable-excipients with said suspension, thereby forming a wet granulation; and

(v) drying said wet granulation.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE US PATENT NO. 8,050,873 PREVIOUSLY RECORDED ON REEL 040183 FRAME 0129. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 22, 2018
From: WARNER CHILCOTT COMPANY, LLC
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 045417/0593 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2016
From: WARNER CHILCOTT COMPANY, LLC
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 040183/0129 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2013
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 031531/0538 →
SECURITY AGREEMENT Recorded Mar 30, 2011
From: WARNER CHILCOTT COMPANY LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026064/0607 →
RELEASE - REEL 023456, FRAME 0052 Recorded Mar 29, 2011
From: CREDIT SUISSSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
To: WARNER CHILCOTT COMPANY LLC
Reel/Frame 026042/0046 →
CHANGE OF NAME Recorded Jun 18, 2009
From: WARNER CHILCOTT COMPANY, INC.
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 022835/0896 →